90B.F SOPHiA GENETICS SA

Healthcare Health Information Services Frankfurt Exchange
7.00 EUR
Close of Nov 11, 2026
3.48 7.55
Market cap
EUR 600M
P/E
-
P/B
8.79x
ROE
-120.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 90B.F undervalued?

Graham number

The Graham number of SOPHiA GENETICS SA cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

SOPHiA GENETICS SA fundamental analysis

No fundamental analysis for SOPHiA GENETICS SA yet.

SOPHiA GENETICS SA stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About SOPHiA GENETICS SA

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry co…

Full company profile